Herbert Smith Freehills Kramer LLP advises leading life sciences companies across the product lifecycle, with notable strength in patent litigation (particularly in generic and biosimilar challenges), commercial disputes and corporate M&A. Alan Montgomery, a ‘standout’ specialist in cross-border M&A, investment and commercial agreements, co-leads the practice alongside Chris Parker KC, who focuses on international arbitrations. Sebastian Moore is noted for his patent litigation capability, running cases in the UK and coordinating cases across Europe. Emily Bottle and Priyanka Madan handle contentious and non-contentious IP and regulatory matters, while Kyriakos Fountoukakos strengthens the firm’s competition offering.
Legal 500 Editorial commentary
Phone
+44 207 466 2801
Email
Profile
Social

Profile

Work Department
Intellectual Property
Position

Partner, London

Career

Sebastian is an IP litigator, with a focus on life sciences.

Sebastian is the Head of IP in UK and is recognised by the legal directories as a leading patent litigator and regularly acts for clients such as Roche, Gilead, Takeda, Sanofi in UK litigation, EPO oppositions and in coordinating actions on a pan-European basis. He has also represented clients in two important references on SPC matters to the CJEU and has been involved in three further CJEU references.

Sebastian is a solicitor advocate with rights of audience in all civil proceedings in the UK and he is a Unified Patents Court representative. He is a member of the International Association for the Protection of Intellectual Property and an associate member of the Chartered Institute of Patent Attorneys.

Sebastian is also a guest lecturer at the University of London (on the Certificate of Intellectual Property course and the LLM course in International and Comparative Patent Law) and a tutor on the Oxford University Diploma in Intellectual Property Law and Practice.

Sebastian is recognised as Leading Individual in Pharmaceuticals and Biotechnology, and led the team which recently won "European Cross-Border Patent and Regulatory Team of the Year 2024" at the MIP Awards.

Content supplied by Herbert Smith Freehills Kramer LLP

Testimonials

Collated independently by Legal 500 research team.

  • 'In life sciences and healthcare, Alan Montgomery is a standout attorney.'

Key clients

  • Gilead Sciences, Inc AbbVie, Inc Roche Genus plc Dr Reddy's Laboratories Biotage AB Johnson Matthey plc CSL Behring Sanofi Biogen

Work highlights

Advised Dr. Reddy's Laboratories Limited on its acquisition of Haleon plc's global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy (NRT) category outside of the United States.
Advised EQT Partners, a global investment firm, and its portfolio company Icon Group (Integrated Clinical Oncology Network) on its acquisition of the Pharmaxo Group.
Advised Millennium Pharmaceuticals, a US-headquartered biopharmaceutical company, and its licensee Johnson & Johnson in the pan-European enforcement of patents relating to Velcade (bortezomib), a first-in-class drug used to treat multiple myeloma and mantle cell lymphoma.